{"news_desk": "SundayBusiness", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Randal J Kirk, owner of Intrexon biotech firm, controls what could be effective weapon against mosquitoes carrying Zika virus; has lobbied government to test company's genetically engineered mosquitoes, which have capacity to mate with wild ones and produce offspring that die before adulthood;  successful outcome could end spread of mosquito-born viruses, progress future of synthetic biology and boost Intrexon\u2019s bottom line.", "type_of_material": "News", "word_count": "2707", "lead_paragraph": "A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But that\u2019s just a start.", "pub_date": "2016-03-06T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "A Biotech Evangelist Seeks a Zika Dividend", "print_headline": "Seeking a Zika Dividend"}, "snippet": "A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But that\u2019s just a start.", "multimedia": [{"height": 126, "url": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2016/03/06/business/06INTREXON2/06INTREXON2-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/03/06/business/06INTREXON2/06INTREXON2-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/03/06/business/a-biotech-evangelist-seeks-a-zika-dividend.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Intrexon Corporation", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Mosquitoes", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Kirk, Randal J (1953- )", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Zika Virus", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Genetic Engineering", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "DNA (Deoxyribonucleic Acid)", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Synthetic Biology", "name": "subject"}], "blog": [], "_id": "56dabd8638f0d83eee097acb", "source": "The New York Times"}